A case report of somnambulism associated with olanzapine
Farhad Faridhosseini1, Azar Zamani2
1Psychiatry and behavioral Sciences Research Center, Ibn-e-Sina Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
Somnambulism consists of a group of behaviors leading to unwanted movements during sleep or even sleepwalking. Medications applied for psychiatric disorders could increase the likelihood of somnambulism in adults. The following article is a case report of somnambulism seen in a patient with schizophrenia, which occurred after remission of an acute episode following treatment with olanzapine. When olanzapine dosage was decreased, no previous and similar symptoms were reported after 6 months of follow up.
Insights
This case report details somnambulism, or sleepwalking, in a schizophrenia patient treated with olanzapine. Reducing the olanzapine dosage resolved the sleepwalking symptoms, suggesting a link between the medication and sleep disturbances.
Area of Science:
- Neurology
- Psychiatry
- Sleep Medicine
Background:
- Somnambulism, characterized by sleepwalking and complex behaviors during sleep, can be influenced by psychiatric medications.
- Antipsychotic medications, particularly those used for schizophrenia, are increasingly recognized for potential side effects impacting sleep architecture.
Observation:
- A case report involving a patient diagnosed with schizophrenia experiencing an episode of somnambulism.
- The somnambulism occurred during the remission phase of an acute psychotic episode, following treatment initiation with olanzapine.
Findings:
- The patient's somnambulism symptoms resolved after a reduction in the olanzapine dosage.
- No recurrence of sleepwalking or related symptoms was observed during a 6-month follow-up period after dosage adjustment.
Implications:
- This case highlights a potential association between olanzapine use and the emergence of somnambulism in patients with schizophrenia.
- Further research is warranted to understand the mechanisms linking atypical antipsychotics to parasomnias and to guide clinical management strategies.
Related Concept Videos
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Narcolepsy
Management of Insomnia
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...


